Alex Kan
Vice President, Finance and Investor Relations
Replay available
Absci Corporation (NASDAQ: ABSI) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.

Vice President, Finance and Investor Relations
Analyst, David Coleman & Company
Analyst, J.P. Morgan
Analyst, Truist
Analyst, Guggenheim Securities
Analyst, Morgan Stanley
Chief Innovation Officer
Chief Financial Officer and Chief Business Officer
Analyst
Founder and Chief Executive Officer
Thank you for standing by. My name is Roselle and I will be your operator today. At this time, I would like to welcome everyone to the ABE PSY Q3 2025 Business Update. All lines have been placed on mute to prevent any background noise. After the speaker remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. Thank you. I will now turn the conference call over to Alex Kan, VP, Finance and Investor Relations. Please go ahead. Thank you. Earlier today, ABSA released the financial and operating results for the quarter ended September 30th, 2025. If you haven't received this news release or if you would like to be added to the company's distribution list, please send an email to investors.absa.com. An archived webcast of this call will be available for replay on Abcide's investor relations website at investors.abcide.com for at least 90 days after this call. Joining me today are Sean McClain, Abcide's founder and CEO, and Zach Jonason, Chief Financial Officer and Chief Business Officer. Andreas Busch, Abcide's Chief Innovation Officer, will also join for Q&A following prepared remarks. Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance in forward-looking statements. Additional information regarding these risks, uncertainties, and factors that could cause results to differ appears in the ...